Author
Listed:
- Jason J. Pitt
(University of Chicago
National University of Singapore)
- Markus Riester
(Novartis Institutes for BioMedical Research)
- Yonglan Zheng
(University of Chicago)
- Toshio F. Yoshimatsu
(University of Chicago)
- Ayodele Sanni
(Lagos State University Teaching Hospital)
- Olayiwola Oluwasola
(University of Ibadan)
- Artur Veloso
(Novartis Institutes for BioMedical Research)
- Emma Labrot
(Novartis Institutes for BioMedical Research)
- Shengfeng Wang
(University of Chicago
Peking University Health Science Center)
- Abayomi Odetunde
(University of Ibadan)
- Adeyinka Ademola
(University of Ibadan)
- Babajide Okedere
(University of Ibadan)
- Scott Mahan
(Novartis Institutes for BioMedical Research)
- Rebecca Leary
(Novartis Institutes for BioMedical Research)
- Maura Macomber
(Novartis Institutes for BioMedical Research)
- Mustapha Ajani
(University of Ibadan)
- Ryan S. Johnson
(Novartis Institutes for BioMedical Research)
- Dominic Fitzgerald
(University of Chicago)
- A. Jason Grundstad
(University of Chicago)
- Jigyasa H. Tuteja
(University of Chicago)
- Galina Khramtsova
(University of Chicago)
- Jing Zhang
(University of Chicago)
- Elisabeth Sveen
(University of Chicago)
- Bryce Hwang
(Novartis Institutes for BioMedical Research)
- Wendy Clayton
(University of Chicago)
- Chibuzor Nkwodimmah
(University of Ibadan)
- Bisola Famooto
(University of Ibadan)
- Esther Obasi
(Lagos State University Teaching Hospital)
- Victor Aderoju
(Lagos State University Teaching Hospital)
- Mobolaji Oludara
(Lagos State University Teaching Hospital)
- Folusho Omodele
(Lagos State University Teaching Hospital)
- Odunayo Akinyele
(University of Chicago)
- Adewunmi Adeoye
(University of Ibadan)
- Temidayo Ogundiran
(University of Ibadan)
- Chinedum Babalola
(University of Ibadan
University of Ibadan)
- Kenzie MacIsaac
(Novartis Institutes for BioMedical Research)
- Abiodun Popoola
(Lagos State University)
- Michael P. Morrissey
(Novartis Institutes for BioMedical Research)
- Lin S. Chen
(University of Chicago)
- Jiebiao Wang
(University of Chicago)
- Christopher O. Olopade
(University of Chicago)
- Adeyinka G. Falusi
(University of Ibadan)
- Wendy Winckler
(Novartis Institutes for BioMedical Research)
- Kerstin Haase
(The Francis Crick Institute)
- Peter Loo
(The Francis Crick Institute
University of Leuven)
- John Obafunwa
(Lagos State University Teaching Hospital)
- Dimitris Papoutsakis
(Novartis Institutes for BioMedical Research)
- Oladosu Ojengbede
(University of Ibadan)
- Barbara Weber
(Novartis Institutes for BioMedical Research)
- Nasiru Ibrahim
(Lagos State University Teaching Hospital)
- Kevin P. White
(University of Chicago
Tempus Labs Inc.)
- Dezheng Huo
(University of Chicago
University of Chicago)
- Olufunmilayo I. Olopade
(University of Chicago
University of Chicago)
- Jordi Barretina
(Novartis Institutes for BioMedical Research
Girona Biomedical Research Institute (IDIBGI))
Abstract
Racial/ethnic disparities in breast cancer mortality continue to widen but genomic studies rarely interrogate breast cancer in diverse populations. Through genome, exome, and RNA sequencing, we examined the molecular features of breast cancers using 194 patients from Nigeria and 1037 patients from The Cancer Genome Atlas (TCGA). Relative to Black and White cohorts in TCGA, Nigerian HR + /HER2 − tumors are characterized by increased homologous recombination deficiency signature, pervasive TP53 mutations, and greater structural variation—indicating aggressive biology. GATA3 mutations are also more frequent in Nigerians regardless of subtype. Higher proportions of APOBEC-mediated substitutions strongly associate with PIK3CA and CDH1 mutations, which are underrepresented in Nigerians and Blacks. PLK2, KDM6A, and B2M are also identified as previously unreported significantly mutated genes in breast cancer. This dataset provides novel insights into potential molecular mechanisms underlying outcome disparities and lay a foundation for deployment of precision therapeutics in underserved populations.
Suggested Citation
Jason J. Pitt & Markus Riester & Yonglan Zheng & Toshio F. Yoshimatsu & Ayodele Sanni & Olayiwola Oluwasola & Artur Veloso & Emma Labrot & Shengfeng Wang & Abayomi Odetunde & Adeyinka Ademola & Babaji, 2018.
"Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features,"
Nature Communications, Nature, vol. 9(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06616-0
DOI: 10.1038/s41467-018-06616-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06616-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.